ALATROFLOXACIN PARENTERAL COMPOSITIONS
The present invention relates to alatrofloxacin mesylate substantially free of less polar impurities, to parenteral compositions of alatrofloxacin mesylate and to processes for purifying alatrofloxacin mesylate.
Saved in:
| Main Authors | , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
12.09.2000
|
| Edition | 7 |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to alatrofloxacin mesylate substantially free of less polar impurities, to parenteral compositions of alatrofloxacin mesylate and to processes for purifying alatrofloxacin mesylate. |
|---|---|
| AbstractList | The present invention relates to alatrofloxacin mesylate substantially free of less polar impurities, to parenteral compositions of alatrofloxacin mesylate and to processes for purifying alatrofloxacin mesylate. |
| Author | ROBERT MARK GUINN GUHAN SUBRAMANIAN SAM LAMBERT JOHN FRANCIS WALINSKY STANLEY WALTER |
| Author_xml | – fullname: ROBERT MARK GUINN – fullname: WALINSKY STANLEY WALTER – fullname: LAMBERT JOHN FRANCIS – fullname: GUHAN SUBRAMANIAN SAM |
| BookMark | eNrjYmDJy89L5WRQc_RxDAnyd_Pxj3B09vRTCHAMcvULcQ1y9FFw9vcN8A_2DPH09wvmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxwd6GBoZGBgYGjsbGRCgBAIuRJT0 |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| Edition | 7 |
| ExternalDocumentID | SK1012000A3 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_SK1012000A33 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:58:21 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_SK1012000A33 |
| Notes | Application Number: SK20000000101 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20000912&DB=EPODOC&CC=SK&NR=1012000A3 |
| ParticipantIDs | epo_espacenet_SK1012000A3 |
| PublicationCentury | 2000 |
| PublicationDate | 20000912 |
| PublicationDateYYYYMMDD | 2000-09-12 |
| PublicationDate_xml | – month: 09 year: 2000 text: 20000912 day: 12 |
| PublicationDecade | 2000 |
| PublicationYear | 2000 |
| RelatedCompanies | PFIZER PRODUCTS INC |
| RelatedCompanies_xml | – name: PFIZER PRODUCTS INC |
| Score | 2.5182097 |
| Snippet | The present invention relates to alatrofloxacin mesylate substantially free of less polar impurities, to parenteral compositions of alatrofloxacin mesylate and... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | ALATROFLOXACIN PARENTERAL COMPOSITIONS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20000912&DB=EPODOC&locale=&CC=SK&NR=1012000A3 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLbGQMANBojxUg-ot4q16YtDhbK01cbapmoL2m2iXZB2GRMr4u_jhnVwgVuUSM5Dcmwn_j4D3NpWKQaCGNpcd4RmOoaplbpOtJIIF825bhuy2ESc2KMn83FqTTuwaLEwkif0U5IjokZVqO-1vK9XP49YvsytXN-VC-x6ewgLz1fb6Bg9Bt1Q_aEXpNznTGXMyydqknkNjRWOUrIDu-hFO032V_A8bEApq98WJTyCvRSFLetj6IhlDw5YW3itB_vx5r8bmxvVW5-ASiNaZDyM-JSycaKkNAsaOlsaKYzHKc_HEhB8CkoYFGyk4YSz7eZm-WS7NHIGXYz5xTkoaEZJ1VC3DCrHdMn83n5xjcrWhflquehi9aH_p5iLf8Yu4fAbS97UQLiCbv3-Ia7RqtbljTyPL47ldgI |
| link.rule.ids | 230,309,783,888,25578,76884 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLbGQIwbDBDj2QPqrWJp-uJQoS5ttdGntoJ6q2gXpF3GxIr4-7hhHVzgFsWS85Ccz07izwC3hl7yIaeqMicmVzRT1ZSSEKqUlFsI58RQRbGJKDbGT9pjrucdWLS5MIIn9FOQI6JFVWjvtTivVz-XWK74W7m-KxfY9fbgZ7Yrt9ExegxEld2R7aWJmzCZMXsWyPHUbmisUOrQHdhFD9tqaPa951GTlLL6jSj-IeylqGxZH0GHL_vQY23htT7sR5v3bmxuTG99DLITOtk08cMkd9gkllJn6jV0tk4osSRKk9lEJASfgOR7GRsrOGCxXVwxC7ZTo6fQxZifn4GEMEqrhrplWJmaRef3xoulVgbh2qtuoYs1gMGfas7_kd1Ab5xFYRFO4uACDr7zypt6CJfQrd8_-BUibF1ei735Aj8lePI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ALATROFLOXACIN+PARENTERAL+COMPOSITIONS&rft.inventor=ROBERT+MARK+GUINN&rft.inventor=WALINSKY+STANLEY+WALTER&rft.inventor=LAMBERT+JOHN+FRANCIS&rft.inventor=GUHAN+SUBRAMANIAN+SAM&rft.date=2000-09-12&rft.externalDBID=A3&rft.externalDocID=SK1012000A3 |